Concepedia
Statistics
Publications
12
Citations
707
H-Index
Active since
2012
Affiliations
University of Cambridge(Current)
Massachusetts General Hospital
Harvard University
AstraZeneca (United Kingdom)
University of Bristol
Siang‐Boon Koh is an author at University of Cambridge specializing in oncology, pharmacology, and molecular oncology.
Publications per year
2012–2025
An automated fitting procedure and software for dose-response curves with multiphasic features
Giovanni Y. Di Veroli, Chiara Fornari, Ian S. Goldlust et al. · Scientific Reports · 2015 · 200 citations · Full text
Medicine, Oncology, Pharmacology +15
A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level
Siang‐Boon Koh, Patrice Mascalchi, Esther Rodríguez et al. · Journal of Cell Science · 2016 · 119 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine <i>In Vitro</i> and <i>In Vivo</i> to Induce Pancreatic Ductal Adenocarcinoma Regression
Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson et al. · Molecular Cancer Therapeutics · 2018 · 110 citations
Medicine, Oncology, Pharmacology +17
CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus
Siang‐Boon Koh, Aurélie Courtin, Richard J. Boyce et al. · Cancer Research · 2015 · 62 citations · Full text
Life Sciences, Oncology, Pharmacology +17
REDD1 loss reprograms lipid metabolism to drive progression of <i>RAS</i> mutant tumors
Shuxi Qiao, Siang‐Boon Koh, Varunika Vivekanandan et al. · Genes & Development · 2020 · 56 citations · Full text
Medicine, Genetics, Oncology +17
1–5 of 12